Vortex Energy【VRTX】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.05

買値

0.045

売値

0.05

出来高

1,501

0.05 日の範囲 0.05

0.04 52 週間の範囲 0.52

前日終値

0.045

始値

0.05

時刻

359

0.05

最終取引時間

02:49:28

平均取引量 (3 か月)

144,485

財務取引量

VWAP

Vertex Pharmaceuticals Announces the Date of its Third Quarter 2006 Financial Results Conference Call and Webcast

CAMBRIDGE, Mass., Oct. 9 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq GS: VRTX) will announce its third quarter 2006 financial results on Thursday, October 26, 2006...

Vertex Pharmaceuticals Announces Completion of Common Stock Offering

CAMBRIDGE, Mass., Sept. 20 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq GS: VRTX) today announced the completion of its public offering of 9,100,000 shares of common...

Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences

CAMBRIDGE, Mass., Sept. 18 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq GS: VRTX) will webcast corporate presentations at Merrill Lynch's Global Pharmaceutical, Biotech...

Vertex Pharmaceuticals Announces Pricing of Common Stock Offering

CAMBRIDGE, Mass., Sept. 14 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq GS: VRTX) today announced the pricing of its public offering of 9,100,000 shares of its common...

Vertex and Merck Initiate Clinical Study in Hematologic Cancers with Aurora Kinase Inhibitor VX-680

Vertex and Merck Initiate Clinical Study in Hematologic Cancers with Aurora Kinase Inhibitor VX-680 WHITEHOUSE STATION, N.J. and CAMBRIDGE, Mass., June 17 /PRNewswire/ -- Merck & Co., Inc...

Vertex Pharmaceuticals Reports Positive Results from First-in-Human Study for VX-950, an Investigational Oral Protease Inhibitor

Vertex Pharmaceuticals Reports Positive Results from First-in-Human Study for VX-950, an Investigational Oral Protease Inhibitor for the Treatment of Hepatitis C -- Encouraging Results Support...

Studies of Sustained Efficacy/Tolerability of LEXIVA After 96 Weeks of Treatment Presented at IAC

Studies of Sustained Efficacy/Tolerability of LEXIVA After 96 Weeks of Treatment Presented at IAC BANGKOK, Thailand, July 13 /PRNewswire-FirstCall/ -- The protease inhibitor (PI) LEXIVA(R...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.005	11.1111111111	0.045	0.05	0.04	50943	0.04220836	CS
4	0.005	11.1111111111	0.045	0.055	0.04	182920	0.04306117	CS
12	-0.015	-23.0769230769	0.065	0.07	0.04	144485	0.04832468	CS
26	-0.155	-75.6097560976	0.205	0.21	0.04	119709	0.07798439	CS
52	-0.46	-90.1960784314	0.51	0.52	0.04	123239	0.20057017	CS
156	-0.05	-50	0.1	2.32	0.04	195248	0.86996642	CS
260	-0.05	-50	0.1	2.32	0.04	195248	0.86996642	CS

VRTX - Frequently Asked Questions (FAQ)

What is the current Vortex Energy share price?

The current share price of Vortex Energy is $ 0.05

What is the 1 year trading range for Vortex Energy share price?

Vortex Energy has traded in the range of $ 0.04 to $ 0.52 during the past year

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
ASTIAquarius Surgical Technologies Inc	$ 0.02 (100.00%)	2k
LTHMChampion Electric Metals Inc	$ 0.015 (50.00%)	20k
TMINTeako Minerals Corp	$ 0.06 (50.00%)	50k
TUGATuga Innovations Inc	$ 0.015 (50.00%)	2k
CKCascadia Blockchain Group Corp	$ 0.045 (50.00%)	35k
ULTAUltra Brands Ltd	$ 0.005 (-66.67%)	224k
LAI.XLa Imperial Resources Inc	$ 0.005 (-50.00%)	1,000
BHCCBlue Horizon Global Capital Corp	$ 0.005 (-50.00%)	63.87k
NXU.XNexco Resources Inc	$ 0.005 (-50.00%)	86k
TGIF1933 Industries Inc	$ 0.005 (-50.00%)	487.45k
PUMPStock Trend Capital Inc	$ 0.01 (0.00%)	2.48M
FUTRGold n Futures Mineral Corp	$ 0.005 (0.00%)	1.93M
HVWHi View Resources Inc	$ 0.055 (0.00%)	1.76M
SPMTSpearmint Resources Inc	$ 0.015 (-25.00%)	1.19M
PNGCLoyalist Exploration Limited	$ 0.005 (0.00%)	959.55k